Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Summary

Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.

Conditions

• Heart Failure
• Valve Heart Disease

Interventions

DIAGNOSTIC_TEST

AI-guided echo

AI-guided echocardiography

DIAGNOSTIC_TEST

Standard echo

Standard echocardiography

Sponsors & Collaborators

• Alice Springs Hospital

  collaborator UNKNOWN

• Princess Alexandra Hospital, Brisbane, Australia

  collaborator OTHER

• Royal Perth Hospital

  collaborator OTHER

• Ochre Health

  collaborator UNKNOWN

• Walgett Aboriginal Medical Services

  collaborator UNKNOWN

• Merriden Health Service

  collaborator UNKNOWN

• Royal Hobart Hospital

  collaborator OTHER_GOV

• Quairading Medical Practice

  collaborator UNKNOWN

• Baker Heart and Diabetes Institute

  lead OTHER

Principal Investigators

• Tom Marwick, MBBS, PhD · Baker Heart and Diabetes Institute

Study Design

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

45 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-02-24

Primary Completion

2026-06-30

Completion

2026-06-30

FDA Device

Yes

Countries

• Australia

Study Locations